Country: Ástralía
Tungumál: enska
Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)
GLYCOSAMINOGLYCAN POLYSULFATE
ELANCO AUSTRALASIA PTY LTD
glycosaminoglycan polysulfat(250mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
GLYCOSAMINOGLYCAN POLYSULFATE EMULSIFIERS & SURFACTANTS Active 250.0 mg/ml
5x1mL Amp
VM - Veterinary Medicine
ELANCO AUSTRALASIA
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
MUSCULOSKELETAL SYSTEM
DEGENERATIVE ASEPTIC JOINT DISEASE | TRAUMATIC DEGENERATIVE JOINT D
Poison schedule: 4; Withholding period: WHP: Meat: 28 days; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; An aid in the treatment of traumatic and degenerative aseptic joint disease in horses.
Registered
2023-07-01
,.. ADEQUAN IA NRA 36012 PAGE 1 OF 4 8.5.2001 VIAL LABEL (1 rnt) PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ADEQUAN® POLYSULPHATED GLYCOSAMINOGLYCAN INJECTION 250 mg/mL BOEHRINGER INGELHEIM _---.....-0::----,.; N.R.A. I APPROVED LABEL ('TEXl') \ Label No: .~iff.?'?:L~§:t?;··l Date: .Q.$."?!~ _..._ _¥P_ _..._ _\_ Sign~wrEl: .,,:'..~/I~H;;.J ".. ADEQUAN IA NRA 36012 PAGE 20F 4 8.5.2001 CARTON LABEL - PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ADEQUAN® POLSULPHATED GLYCOSAMINOGLYCAN INJECTION 250 mglmL An aid in the treatment of traumatic and degenerative aseptic joint disease in horses 5 x 1 mL ampoules READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE Administer the contents of 1 ampoule (1 mL) by intra-articular injection into the affected joint once weekly for five weeks. The joint area must be shaved, cleansed and sterilised prior to administration to prevent joint infection. MEAT WITHHOLDING PERIOD 2A/DAYS. Disposal Dispose of empty container by wrapping with paper and putting in garbage. Store below 25°C (air conditioning) NRA 360121 Batch No.: Expiry Date: Boehringer Ingelheim Janssen Pharmaceutica ,.. ADEQUAN IA NRA 36012 PAGE 30F 4 8.5.2001 PACKAGING INSERT - PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ADEQUAN® Polysulphated Glycosaminoglycan Injection 250 mglmL INDICATION Adequan" is for use as an aid in the treatment of traumatic and degenerative aseptic joint disease in horses. In healthy cartilage the synthesis and degradation of cartilage is in equilibrium. In traumatic and degenerative joint disease this balance is shifted towards increasing degradation. This results in a loss of mucopolysaccharides which are the basic building blocks of cartilage. The destruction of joint cartilage progresses unless the process is reversed. Adsquan" is similar to the mucopolysaccharides of cartilage and is concentrated in cartilaginous tissue. Adsquan" exerts its activi Lestu allt skjalið